IP Library Granted Patent US 11,299,533
Granted Patent B2
US 11,299,533 · App. 16/015,452 · Granted Apr 12, 2022

Purification of factor VIII subspecies

Inventors: Meinhard Hasslacher (Vienna, AT); Martin Feichtinger (Vienna, AT); Philipp M. Bärnthaler (Vienna, AT); Christa Mayer (Wolfsthal, AT); Birgit Reipert (Deutsch-Wagram, AT); Mantas Malisauskas (Vienna, AT); Julia Anzengruber (Vienna, AT)
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
C07K14/755B01D15/327B01D15/34B01D15/363C07K1/16C07K1/18C07K1/36A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,299,533
App. No.
16/015,452
Granted
Apr 12, 2022
Kind
B2
Abstract

The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.

Claims (21)

1. A method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising the steps of:

(1) subjecting the composition comprising FVIII to anion exchange chromatography, and collecting the eluate comprising said FVIII subspecies;

(2) subjecting the eluate of step (1) comprising said FVIII subspecies to size exclusion chromatography, and collecting the eluate comprising said FVIII subspecies; and

(3) concentrating the eluate of step (2) comprising said FVIII subspecies,

wherein said FVIII subspecies is a FVIII heavy chain that is associated with a FVIII light chain, and wherein the weight ratio of said FVIII subspecies in the composition is increased as compared to all other FVIII subspecies comprising a FVIII heavy chain that is associated with a FVIII light chain.

2. The method according to claim 1 , wherein the concentration step (3) is a step of subjecting the eluate of step (2) comprising said FVIII subspecies to anion exchange chromatography, and collecting the eluate comprising said FVIII subspecies.

3. The method according to claim 1 , wherein FVIII is recombinant FVIII (rFVIII) and said FVIII subspecies is a recombinant FVIII (rFVIII) subspecies.

4. The method according to claim 1 , wherein in step (1) a high resolution Q-resin with a bead size of less than 20 μm is used for anion exchange chromatography.

5. The method according to claim 1 , wherein in step (2) a size exclusion chromatography resin with a resolution range of 10000 Da to 60000 Da is used for size exclusion chromatography.

6. The method according to claim 1 , wherein the method additionally comprises the following step (0) prior to step (1):

(0) subjecting the FVIII comprised in the composition to furin protease treatment.

7. The method according to claim 1 , wherein elution in step (1) is performed by linear gradient elution, and wherein the gradient of the linear gradient elution has a length of at least about 16 column volumes, at least about 24 column volumes, or at least about 32 column volumes.

8. A method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising the steps of:

(1) subjecting the composition comprising FVIII to anion exchange chromatography, and collecting the eluate comprising said FVIII subspecies;

(2) subjecting the eluate of step (1) comprising said FVIII subspecies to hydrophobic interaction chromatography, and wherein the hydrophobic interaction chromatography is negative mode chromatography; and

(3) concentrating the eluate of step (2) comprising said FVIII subspecies,

wherein said FVIII subspecies is a FVIII heavy chain that is associated with a FVIII light chain, and wherein the weight ratio of said FVIII subspecies in the composition is increased as compared to all other FVIII subspecies comprising a FVIII heavy chain that is associated with a FVIII light chain.

9. A method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising the steps of:

(1) subjecting the composition comprising FVIII to anion exchange chromatography, and collecting the eluate comprising said FVIII subspecies; and

(2) concentrating the eluate of step (1) comprising said FVIII subspecies,

wherein said FVIII subspecies is the FVIII 90 kDa heavy chain associated with a FVIII light chain and wherein the weight ratio of said FVIII subspecies in the composition is increased as compared to all other FVIII subspecies comprising a FVIII heavy chain that is associated with a FVIII light chain.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0177 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PLEASE REMOVE INCORRECTLY LISTED APPLICATION NOS. 16164208 AND 12437384 PREVIOUSLY RECORDED ON REEL 052461 FRAME 0016. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF ADDRESS. Recorded Jan 8, 2021
From: BAXALTA GMBH
To: BAXALTA GMBH
Reel/Frame 055489/0050 →
CHANGE OF ADDRESS Recorded Feb 7, 2020
From: BAXALTA GMBH
To: BAXALTA GMBH
Reel/Frame 052461/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2019
From: HASSLACHER, MEINHARD; FEICHTINGER, MARTIN; BARNTHALER, PHILIPP M.; MAYER, CHRISTA; REIPERT, BIRGIT; MALISAUSKAS, MANTAS; ANZENGRUBER, JULIA
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 048091/0456 →